Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Number of holders
-
961
-
Total 13F shares, excl. options
-
213,693,704
-
Shares change
-
+608,169
-
Total reported value, excl. options
-
$90,176,303,862
-
Value change
-
+$321,462,904
-
Put/Call ratio
-
1.82%
-
Number of buys
-
454
-
Number of sells
-
-406
-
Price
-
$422.24
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q1 2015
1,060 filings reported holding BIIB - BIOGEN INC. - COM as of Q1 2015.
BIOGEN INC. - COM (BIIB) has 961 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 213,693,704 shares
.
Largest 10 shareholders include FMR LLC (22,041,151 shares), PRIMECAP MANAGEMENT CO/CA/ (16,558,763 shares), VANGUARD GROUP INC (13,142,336 shares), PRICE T ROWE ASSOCIATES INC /MD/ (10,791,562 shares), STATE STREET CORP (9,785,190 shares), Clearbridge Investments, LLC (8,025,241 shares), BlackRock Institutional Trust Company, N.A. (6,220,983 shares), JPMORGAN CHASE & CO (5,853,035 shares), JENNISON ASSOCIATES LLC (5,095,601 shares), and SANDS CAPITAL MANAGEMENT, LLC (5,009,615 shares).
This table shows the top 961 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.